Abstract
The invention provides specific peptides derived from the cytotoxicity receptor NKp44 useful for preventing and treating serious diseases including in particular cancer. The invention further relates to compositions comprising a fragment of the extracellular region of NKp44 for preventing or treating cancer.
| Original language | English |
|---|---|
| Patent number | US2015105334 |
| IPC | C07K 7/ 08 A I |
| Priority date | 22/09/14 |
| State | Published - 16 Apr 2015 |
